Clinical Trial Update: A First-in-human, Clinical Trial Assessing the Safety of ES2B-C001-S01 With or Without [Adjuvant] in Patients With HER2-expressing Metastatic Breast Cancer. [Phase 1]

View source ↗

Summary

This is a first-in-human Phase 1 clinical trial to assess the safety of ES2B-C001-S01 (with or without adjuvant) in patients with HER2-expressing metastatic bre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ES2B-C001-S01

Snippet

Sponsor: ExpreS2ion Biotechnologies | Conditions: Breast Cancer, Breast Cancer Metastatic | Phase 1 | Status: RECRUITING